N-(2,4-DIMETHOXYBENZYL)-5-FLUOROTHIAZOL-2-AMINE, 90.0%, 5g

5-Bromo-2-iodo-m-xylene, 97.0%, 25g

1-Hydroxycyclobutanecarboxylic acid, 97.0%, 100mg

2-Amino-4-chloro-5-iodobenzoic acid, 97%, 1g

4,6-Dichloro-5-nitropyrimidine, 97.0%, 5g

1-(2-Bromo-4-(trifluoromethyl)phenyl)ethanone, 95.0%, 250mg

Flacons d'échantillon ROTILABO® avec filetage court ND9 silanisé, Verre marron, avec espace d'inscription, 1,5 ml, 100 Pièce(s)

3,4-Dibenzoylforoxan, 5g

n-heptane, min.95%, pour la synthèse, 10 l, avec bl.

3-(2-Benzyloxy-phenyl)-5-chloromethyl-[1,2,4]oxadiazole, 97.0%, 1g

2-(Methylthio)phenylboronic Acid (contains varying amounts of Anhydride)1g

Triethyl 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate, 97%, 10g

N-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PENTANAMIDE, 95%, 1g